Patient perceptions of multiple sclerosis and its treatment
Open Access
- 1 April 2012
- journal article
- research article
- Published by Informa UK Limited in Patient Preference and Adherence
- Vol. 6, 263-273
- https://doi.org/10.2147/ppa.s27038
Abstract
Peer reviewed article authored by (de Seze J, Borgel F, Brudon F). Read article or submit your manuscript for publishing.Keywords
This publication has 23 references indexed in Scilit:
- The Global Adherence Project (GAP): a multicenter observational study on adherence to disease‐modifying therapies in patients with relapsing‐remitting multiple sclerosisEuropean Journal of Neurology, 2010
- Medication adherence with disease modifying treatments for multiple sclerosis among US employeesJournal of Medical Economics, 2010
- Impact of Adherence to Interferons in the Treatment of Multiple SclerosisClinical Drug Investigation, 2010
- The Cost of Disability and Medically Related Absenteeism Among Employees with Multiple Sclerosis in the USPharmacoEconomics, 2009
- Adherence to the immunomodulatory drugs for multiple sclerosis: contrasting factors affect stopping drug and missing dosesPharmacoepidemiology and Drug Safety, 2008
- Medication Compliance and Persistence: Terminology and DefinitionsValue in Health, 2008
- Twenty‐four‐month comparison of immunomodulatory treatments – a retrospective open label study in 308 RRMS patients treated with beta interferons or glatiramer acetate (Copaxone®)European Journal of Neurology, 2005
- A post-marketing study on interferon 1b and 1a treatment in relapsing-remitting multiple sclerosis: different response in drop-outs and treated patientsJournal of Neurology, Neurosurgery & Psychiatry, 2003
- Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosisAnnals of Neurology, 1996
- Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosisNeurology, 1995